BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37902135)

  • 1. Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases.
    Sehgal IS; Dhooria S; Muthu V; Salzer HJF; Agarwal R
    Curr Opin Pulm Med; 2024 Mar; 30(2):156-166. PubMed ID: 37902135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge.
    Allwood BW; Byrne A; Meghji J; Rachow A; van der Zalm MM; Schoch OD
    Respiration; 2021; 100(8):751-763. PubMed ID: 33401266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-tuberculosis lung disease and chronic obstructive pulmonary disease.
    Gai X; Allwood B; Sun Y
    Chin Med J (Engl); 2023 Aug; 136(16):1923-1928. PubMed ID: 37455331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-tuberculosis lung disease: a neglected disease].
    Ma Y; Ye XP; Fu XY; Wu GH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):955-959. PubMed ID: 36207951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis.
    Allwood BW; Maasdorp E; Kim GJ; Cooper CB; Goldin J; van Zyl-Smit RN; Bateman ED; Dawson R
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1039-1047. PubMed ID: 32494129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term management of people with post-tuberculosis lung disease.
    Seo W; Kim HW; Kim JS; Min J
    Korean J Intern Med; 2024 Jan; 39(1):7-24. PubMed ID: 38225822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and imaging signatures in post tuberculosis lung disease.
    Singh S; Allwood BW; Chiyaka TL; Kleyhans L; Naidoo CC; Moodley S; Theron G; Segal LN
    Tuberculosis (Edinb); 2022 Sep; 136():102244. PubMed ID: 36007338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.
    Amaral AF; Coton S; Kato B; Tan WC; Studnicka M; Janson C; Gislason T; Mannino D; Bateman ED; Buist S; Burney PG;
    Eur Respir J; 2015 Oct; 46(4):1104-12. PubMed ID: 26113680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis, bronchiectasis and chronic airflow obstruction.
    Jordan TS; Spencer EM; Davies P
    Respirology; 2010 May; 15(4):623-8. PubMed ID: 20409028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.
    Meghji J; Lesosky M; Joekes E; Banda P; Rylance J; Gordon S; Jacob J; Zonderland H; MacPherson P; Corbett EL; Mortimer K; Squire SB
    Thorax; 2020 Mar; 75(3):269-278. PubMed ID: 32102951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advances in post-tuberculosis lung disease].
    Deng MH; Zhang SY; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):1041-1045. PubMed ID: 36207960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?
    Malefane L; Maarman G
    Chem Biol Interact; 2024 Jan; 387():110817. PubMed ID: 38006959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airflow obstruction and chronic obstructive pulmonary disease are common in pulmonary tuberculosis even without sequelae findings on chest X-ray.
    Park HJ; Byun MK; Lee J; Kim CY; Shin S; Kim Y; Rhee CK; Jung KS; Yoo KH
    Infect Dis (Lond); 2023 Aug; 55(8):533-542. PubMed ID: 37243367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pay attention to prevention and treatment of post-tuberculosis lung disease].
    Tang SJ; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):951-954. PubMed ID: 36207950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey.
    Xing Z; Sun T; Janssens JP; Chai D; Liu W; Tong Y; Wang Y; Ma Y; Pan M; Cui J; Wang C; Guo Y
    Thorax; 2023 Mar; 78(3):274-280. PubMed ID: 35361688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cough of more than two weeks - Time to think beyond pulmonary TB.
    Chopra M; Bhattacharyya D; Barthwal MS; Madan GDS; Chakrabarthy B; Pandey IM; Chopra M
    Indian J Tuberc; 2019 Jan; 66(1):44-48. PubMed ID: 30797282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.
    Neuböck MJ; ; Günther G; Barac A; Davidsen JR; Laursen CB; Agarwal R; Sehgal IS; Lange C; Salzer HJF
    Semin Respir Crit Care Med; 2024 Feb; 45(1):102-113. PubMed ID: 38196060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.